Pricing Log in Create free account

Aditxt, Inc. (ADTX) vs Skye Bioscience, Inc. (SKYE)

Aditxt, Inc. and Skye Bioscience, Inc. are both Biotechnology companies. Aditxt, Inc. and Skye Bioscience, Inc. are of similar size ($4.6M and $4.4M). Skye Bioscience, Inc. has the higher net margin (0.00% vs −372,998.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Skye Bioscience, Inc. leads on 7 and Aditxt, Inc. on 5.

Valuation

Metric ADTX SKYE Biotechnology median
P/E n/m n/m 10.60
P/S n/m 16.46 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 73.26 3.61 9.02
Earnings yield 0.00% (1,026.26%) (32.88%)
Free cash flow yield 0.00% (779.11%) (23.13%)

Profitability

Metric ADTX SKYE Biotechnology median
Gross margin 20.28% 68.04% 68.51%
Operating margin (128,143.36%) 0.00% 0.00%
Net margin (372,998.60%) 0.00% 0.00%
Free cash flow margin (129,979.72%) 0.00% 0.00%
Return on equity 549.59% (233.87%) (51.96%)
Return on assets (236.38%) (159.80%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADTX SKYE Biotechnology median
Revenue growth (TTM) (74.19%) — 6.76%
EPS growth (last fiscal year) 99.96% (93.15%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADTX SKYE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.06 0.95 4.97
Net debt to EBITDA 0.18 0.45 1.01

Dividend

Metric ADTX SKYE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADTX SKYE Biotechnology median
Market cap 4.39m 4.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack